Cristina Csimma has become chair of the board of directors of Finland-based Forendo Pharma Ltd as the company advances development of its lead compound for endometriosis. Dr Csimma was previously executive chair of Exonics Therapeutics, now owned by Vertex Pharmaceuticals Inc, and board director of the women’s health company Juniper Pharmaceuticals Inc. She was also the president and founding chief executive of Cydan Development Inc, an orphan drug accelerator. She holds a doctor of pharmacy and bachelor of science from the Massachusetts College of Pharmacy as well as a master of health professions from Northeastern University in the US.
Forendo Pharma announced the appointment on 16 September 2020.
Copyright 2020 Evernow Publishing Ltd